These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 15907910

  • 1. Pulmonary hypertension: inhaled nitric oxide, sildenafil and natriuretic peptides.
    Steiner MK, Preston IR, Klinger JR, Hill NS.
    Curr Opin Pharmacol; 2005 Jun; 5(3):245-50. PubMed ID: 15907910
    [Abstract] [Full Text] [Related]

  • 2. Acute pulmonary hypertension in infants and children: cGMP-related drugs.
    Fraisse A, Wessel DL.
    Pediatr Crit Care Med; 2010 Mar; 11(2 Suppl):S37-40. PubMed ID: 20216161
    [Abstract] [Full Text] [Related]

  • 3. Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells.
    Wharton J, Strange JW, Møller GM, Growcott EJ, Ren X, Franklyn AP, Phillips SC, Wilkins MR.
    Am J Respir Crit Care Med; 2005 Jul 01; 172(1):105-13. PubMed ID: 15817798
    [Abstract] [Full Text] [Related]

  • 4. Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study.
    Ghofrani HA, Voswinckel R, Reichenberger F, Olschewski H, Haredza P, Karadaş B, Schermuly RT, Weissmann N, Seeger W, Grimminger F.
    J Am Coll Cardiol; 2004 Oct 06; 44(7):1488-96. PubMed ID: 15464333
    [Abstract] [Full Text] [Related]

  • 5. Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease.
    Schulze-Neick I, Hartenstein P, Li J, Stiller B, Nagdyman N, Hübler M, Butrous G, Petros A, Lange P, Redington AN.
    Circulation; 2003 Sep 09; 108 Suppl 1():II167-73. PubMed ID: 12970227
    [Abstract] [Full Text] [Related]

  • 6. Low-dose phosphodiesterase inhibition improves responsiveness to inhaled nitric oxide in isolated lungs from endotoxemic rats.
    Klein A, Zils U, Bopp C, Gries A, Martin E, Gust R.
    J Surg Res; 2007 Apr 09; 138(2):224-30. PubMed ID: 17275845
    [Abstract] [Full Text] [Related]

  • 7. Cardioprotection with phosphodiesterase-5 inhibition--a novel preconditioning strategy.
    Kukreja RC, Ockaili R, Salloum F, Yin C, Hawkins J, Das A, Xi L.
    J Mol Cell Cardiol; 2004 Feb 09; 36(2):165-73. PubMed ID: 14871543
    [Abstract] [Full Text] [Related]

  • 8. Phosphodiesterase type 5 and high altitude pulmonary hypertension.
    Aldashev AA, Kojonazarov BK, Amatov TA, Sooronbaev TM, Mirrakhimov MM, Morrell NW, Wharton J, Wilkins MR.
    Thorax; 2005 Aug 09; 60(8):683-7. PubMed ID: 16061711
    [Abstract] [Full Text] [Related]

  • 9. Type 5 phosphodiesterase inhibition in heart failure and pulmonary hypertension.
    Lewis GD, Semigran MJ.
    Curr Heart Fail Rep; 2004 Dec 09; 1(4):183-9. PubMed ID: 16036043
    [Abstract] [Full Text] [Related]

  • 10. Sildenafil can increase the response to inhaled nitric oxide.
    Bigatello LM, Hess D, Dennehy KC, Medoff BD, Hurford WE.
    Anesthesiology; 2000 Jun 09; 92(6):1827-9. PubMed ID: 10839936
    [No Abstract] [Full Text] [Related]

  • 11. Signaling molecules in overcirculation-induced pulmonary hypertension in piglets: effects of sildenafil therapy.
    Rondelet B, Kerbaul F, Van Beneden R, Motte S, Fesler P, Hubloue I, Remmelink M, Brimioulle S, Salmon I, Ketelslegers JM, Naeije R.
    Circulation; 2004 Oct 12; 110(15):2220-5. PubMed ID: 15466636
    [Abstract] [Full Text] [Related]

  • 12. [Treatment of pulmonary arterial hypertension: phosphodiesterase-5 inhibitors].
    Ghofrani HA, Grimminger F.
    Dtsch Med Wochenschr; 2006 Dec 08; 131(49 Suppl 9):S311-4. PubMed ID: 17139594
    [Abstract] [Full Text] [Related]

  • 13. [Phosphodiesterase inhibitors in clinical practice. The present and the future. Part II].
    Baksheev BI, Kolomiets NM.
    Klin Med (Mosk); 2007 Dec 08; 85(4):4-11. PubMed ID: 17564028
    [Abstract] [Full Text] [Related]

  • 14. Effects of phosphodiesterase 5 inhibitor on pulmonary vascular reactivity in the fetal lamb.
    Jaillard S, Larrue B, Deruelle P, Delelis A, Rakza T, Butrous G, Storme L.
    Ann Thorac Surg; 2006 Mar 08; 81(3):935-42. PubMed ID: 16488698
    [Abstract] [Full Text] [Related]

  • 15. Use of sildenafil to facilitate weaning from inhaled nitric oxide in children with pulmonary hypertension following surgery for congenital heart disease.
    Lee JE, Hillier SC, Knoderer CA.
    J Intensive Care Med; 2008 Mar 08; 23(5):329-34. PubMed ID: 18701525
    [Abstract] [Full Text] [Related]

  • 16. Sildenafil, a PDE5 inhibitor, in the treatment of pulmonary hypertension.
    Hemnes AR, Champion HC.
    Expert Rev Cardiovasc Ther; 2006 May 08; 4(3):293-300. PubMed ID: 16716091
    [Abstract] [Full Text] [Related]

  • 17. Long-term inhaled nitric oxide plus phosphodiesterase 5 inhibitors for severe pulmonary hypertension.
    Pérez-Peñate GM, Juliá-Serdà G, Ojeda-Betancort N, García-Quintana A, Pulido-Duque J, Rodríguez-Pérez A, Cabrera-Navarro P, Gómez-Sánchez MA.
    J Heart Lung Transplant; 2008 Dec 08; 27(12):1326-32. PubMed ID: 19059113
    [Abstract] [Full Text] [Related]

  • 18. Intravenous dipyridamole enhances the effects of inhaled nitric oxide and prevents rebound pulmonary hypertension in piglets.
    Foubert L, De Wolf D, Mareels K, Van Belleghem Y, Reyntjens K, Mortier E, Van Nooten G.
    Pediatr Res; 2002 Nov 08; 52(5):730-6. PubMed ID: 12409521
    [Abstract] [Full Text] [Related]

  • 19. Sildenafil in neonatal pulmonary hypertension due to impaired alveolarisation and plexiform pulmonary arteriopathy.
    Chaudhari M, Vogel M, Wright C, Smith J, Haworth SG.
    Arch Dis Child Fetal Neonatal Ed; 2005 Nov 08; 90(6):F527-8. PubMed ID: 16244212
    [Abstract] [Full Text] [Related]

  • 20. Sildenafil is a pulmonary vasodilator in awake lambs with acute pulmonary hypertension.
    Weimann J, Ullrich R, Hromi J, Fujino Y, Clark MW, Bloch KD, Zapol WM.
    Anesthesiology; 2000 Jun 08; 92(6):1702-12. PubMed ID: 10839922
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.